Maina, T., Konijnenberg, M. W., KolencPeitl, P., Garnuszek, P., Nock, B. A., Kaloudi, A., . . . Decristoforo, C. (2016). Preclinical pharmacokinetics, biodistribution, radiation dosimetry and toxicity studies required for regulatory approval of a phase I clinical trial with (111)In-CP04 in medullary thyroid carcinoma patients. Eur J Pharm Sci.
Styl ChicagoMaina, Theodosia, et al. "Preclinical Pharmacokinetics, Biodistribution, Radiation Dosimetry and Toxicity Studies Required for Regulatory Approval of a Phase I Clinical Trial With (111)In-CP04 in Medullary Thyroid Carcinoma Patients." Eur J Pharm Sci 2016.
Citace podle MLAMaina, Theodosia, et al. "Preclinical Pharmacokinetics, Biodistribution, Radiation Dosimetry and Toxicity Studies Required for Regulatory Approval of a Phase I Clinical Trial With (111)In-CP04 in Medullary Thyroid Carcinoma Patients." Eur J Pharm Sci 2016.